| Behçet's disease and hearing loss |
| |
| 引用本文： | AK E,Harputluoglu U,Oghan F,Baykal B. Behçet's disease and hearing loss[J]. Auris, nasus, larynx, 2004, 31(1): 29-33. DOI: 10.1016/j.anl.2003.07.006 |
| |
| 作者姓名： | AK E Harputluoglu U Oghan F Baykal B |
| |
| 摘 要： | ![]()
|
| 收稿时间： | 2003-03-12 |
Behçet’s disease and hearing loss |
| |
| AK Erdinç,Harputluoglu Ugur,Oghan Fatih,Baykal Bahadýr. Behçet’s disease and hearing loss[J]. Auris, nasus, larynx, 2004, 31(1): 29-33. DOI: 10.1016/j.anl.2003.07.006 |
| |
| Authors: | AK Erdinç Harputluoglu Ugur Oghan Fatih Baykal Bahadýr |
| |
| Affiliation: | 1. Department of Otorhinolaryngology-Head and Neck Surgery, SSK Göztepe Hospital, Istanbul Turkey;2. Department of Otorhinolaryngology-Head and Neck Surgery, Düzce Faculty of Medicine, University of Abant Izzet Baysal, AIBU Düzce Tip Fakültesi KBB AD, Konuralp, Duzce 81620, Turkey;3. Clinic of Otorhinolaryngology, SSK Tekirdag Çerkezköy Hospital, Tekirdag, Turkey;1. Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran;2. Cochlear Implant Center and Department of Otorhinolaryngology, Amir Aalam Hospital, Tehran University of Medical Sciences, Tehran, Iran;3. Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran;4. Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran;5. Department of Otorhinolaryngology, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;6. Genetics Laboratory, Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran;7. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;8. Department of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran;9. Genomic Center, School of Advanced Sciences, Tehran Medical Branch, Islamic Azad University, Tehran, Iran;10. Research Center for Cognitive and Behavioral Sciences, Tehran University of Medical Sciences, Tehran, Iran;1. Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul, Istanbul, Turkey 81310;2. Divison of Gastroenterology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey;3. Department of Radiology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey;1. Division of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey;3. Division of Hematology, School of Medicine, Marmara University, Istanbul, Turkey;4. Department of Dermatology, School of Medicine, Marmara University, Istanbul, Turkey;2. Department of Cardiovascular Surgery, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey;1. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran;2. Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran |
| |
| Abstract: | ![]()
Objectives: The aim of this study was to determine the incidence and severity of hearing loss in different frequencies in Behçet’s patients in a Turkish population. Material and method: Sixty-three consecutive cases with Behçet’s syndrome and 63 sex- and age-matched healty subjects as control group were included in this study. A detailed history was taken, all patients underwent neuro-otolological, ophthalmologic and dermatologic examination. Audiometric pure-tone thresholds at 125–8000 Hz were obtained in all subjects in both groups. The results of the two groups were statistically evaluated by Chi-square, Student’s-t and McNemar tests. Results: In 35 patients (55%), a hearing loss equal or more than 30 dB hearing level was detected. 24 of 35 patients (68%) showed hearing loss in the higher frequencies (6 and 8 kHz). 12 of 35 patients (34%) showed hearing loss in speech frequencies (500–2000 Hz). No relationship could be found between hearing loss and other system involvements in Behçet’s group. Also there was no correlation between hearing loss and duration of the disease, but the mean age of Behçet’s patients with hearing loss was found to be significantly higher than the mean age of the patients without hearing loss. Conclusion: We suggest that presence of hearing loss in Behçet’s disease is prevalent and represents a fourth clinical symptom after oral, genital ulcers and skin lesions and especially there is a statistically significant hearing loss at high frequencies when compared with the speech frequencies. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
